Bellevue Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-16,000
| Closed | -$887K | – | 151 |
|
2025
Q1 | $887K | Buy |
+16,000
| New | +$887K | 0.02% | 108 |
|
2024
Q4 | – | Sell |
-15,109
| Closed | -$871K | – | 172 |
|
2024
Q3 | $871K | Buy |
+15,109
| New | +$871K | 0.01% | 121 |
|
2022
Q3 | – | Sell |
-42,300
| Closed | -$2.12M | – | 185 |
|
2022
Q2 | $2.12M | Sell |
42,300
-1,300
| -3% | -$65K | 0.03% | 127 |
|
2022
Q1 | $2.24M | Buy |
+43,600
| New | +$2.24M | 0.03% | 131 |
|
2021
Q4 | – | Sell |
-67,000
| Closed | -$3.23M | – | 218 |
|
2021
Q3 | $3.23M | Sell |
67,000
-1,000
| -1% | -$48.2K | 0.03% | 141 |
|
2021
Q2 | $3.58M | Buy |
+68,000
| New | +$3.58M | 0.04% | 135 |
|
2020
Q4 | – | Sell |
-57,000
| Closed | -$2.86M | – | 227 |
|
2020
Q3 | $2.86M | Hold |
57,000
| – | – | 0.04% | 137 |
|
2020
Q2 | $2.91M | Buy |
+57,000
| New | +$2.91M | 0.04% | 129 |
|